DUPILUMAB SIGNIFICANTLY IMPROVES CLINICAL EFFICACY IN PEDIATRIC ATOPIC DERMATITIS PATIENTS <12 YEARS OF AGE

被引:0
|
作者
Katelaris, Constance [1 ,2 ]
Baselga, Eulalia [3 ]
Ramien, Michele [4 ,5 ]
Marcoux, Danielle [6 ,7 ]
de Graaf, Marlies [8 ]
Irvine, Alan [9 ]
Carvalho, Vania Oliveira [10 ]
Ardusso, Ledit R. F. [11 ]
Toledo-Bahena, Mirna [12 ]
Gupta, Rajan [13 ]
Tong, Thu [14 ]
Zhang, Annie [13 ]
机构
[1] Campbelltown Hosp, Campbelltown, Australia
[2] Western Sydney Univ, Sydney, Australia
[3] Hosp St Joan Deu, Barcelona, Spain
[4] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada
[5] Univ Calgary, Calgary, AB, Canada
[6] Univ Montreal, Montreal, PQ, Canada
[7] CHU St Justine Univ Hosp Ctr, Montreal, PQ, Canada
[8] Univ Med Ctr Utrecht, Utrecht, Netherlands
[9] Trinity Coll Dublin, Dublin, Ireland
[10] Univ Fed Parana, Hosp Clin, Curitiba, Brazil
[11] Natl Univ Rosario, Sch Med, Rosario, Argentina
[12] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, Mexico
[13] Sanofi, Cambridge, MA USA
[14] Regeneron Pharmaceut Inc, Tarrytown, NY USA
关键词
D O I
10.1111/imj.81_16230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P82
引用
收藏
页码:29 / 29
页数:1
相关论文
共 50 条
  • [31] Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study
    Yang, Dan-Yang
    Li, Li
    Lu, Tao
    Jing, Wen-Wen
    Liu, Xin
    Li, Xiao-Li
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (03) : 467 - 472
  • [32] Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study
    Dan-Yang Yang
    Li Li
    Tao Lu
    Wen-Wen Jing
    Xin Liu
    Xiao-Li Li
    Archives of Dermatological Research, 2023, 315 : 467 - 472
  • [33] Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study
    Zhou, Xiyuan
    Yang, Ge
    Chen, Xuejun
    Zhang, Lixia
    DRUGS & AGING, 2023, : 933 - 940
  • [34] Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study
    Zhou, Xiyuan
    Yang, Ge
    Chen, Xuejun
    Zhang, Lixia
    DRUGS & AGING, 2023,
  • [35] Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study
    Napolitano, M.
    Fabbrocini, G.
    Scalvenzi, M.
    Blasio, C.
    Stingeni, L.
    Patruno, C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (07) : 888 - 890
  • [36] Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study
    Xiyuan Zhou
    Ge Yang
    Xuejun Chen
    Lixia Zhang
    Drugs & Aging, 2023, 40 (10) : 933 - 940
  • [37] DUPILUMAB TREATMENT NORMALIZES SKIN BARRIER STRUCTURE AND FUNCTION AND IMPROVES CLINICAL OUTCOMES IN PATIENTS WITH ATOPIC DERMATITIS
    Bissonnette, Robert
    Goleva, Elena
    Berdyshev, Evgeny
    Agueusop, Inoncent
    Praestgaard, Amy
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 42 - 43
  • [38] Assessment of the efficacy and safety of dupilumab combined with cyclosporine A in patients with atopic dermatitis
    Liu, Xiaotao
    Wang, Lifeng
    Zheng, Lingling
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (07) : 1463 - 1468
  • [39] INFECTIONS IN DUPILUMAB PEDIATRIC CLINICAL TRIALS IN ATOPIC DERMATITIS (AD) - A POOLED ANALYSIS
    Paller, A.
    Beck, L.
    Blauvelt, A.
    Cork, M.
    Wollenberg, A.
    Chen, Z.
    Bates, L.
    Cyr, S.
    Zhang, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S16 - S17
  • [40] Dupilumab Efficacy in Children With Atopic Dermatitis Aged 6 Months to 5 Years With and Without Atopic Comorbidities
    Boguniewicz, Mark
    Sher, Lawrence
    Paller, Amy
    Chen, Zhen
    Shah, Parul
    Rodriguez-Marco, Ainara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB148 - AB148